Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04312620
Other study ID # ILM peeling
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2020
Est. completion date April 8, 2021

Study information

Verified date February 2020
Source Assiut University
Contact almoatz bellah zohier mohamm,ed, master
Phone 01099490013
Email moatazmoh58@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evulate changes in VF and OCT after viterctomy associated with ILM peeling.


Description:

Macular epiretinal membrane (ERM) is a disorder of the vitreomacular interface characterized by fibrocellular proliferation on the anterior surface of the internal limiting membrane (ILM) of the macula. Pars plana vitrectomy with ERM removal and inner limiting membrane peeling is the standard surgical treatment for an ERM. ILM peeling is performed to eliminate the scaffold for myofibroblast proliferation and any microscopic ERM in order to prevent ERM recurrence. ILM peeling is indicated for other pathologies other than ERM such as, diabetic macular edema, and macular hole. ILM peeling is a traumatic procedure that may have many effects on the underlying inner retinal layers that may lead to changes in retinal function.

Retinal edema, eccentric scotoma, dissociation of the nerve fiber layer, iatrogenic punctuate chorioretinopathy, and subretinal, retinal, and vitreous hemorrhage are well described secondary to the surgical trauma of peeling in addition to stain toxicity. Investigation of these changes may assist in aiding the development of minimally traumatic techniques for ILM removal .

Evaluation of functional changes may include visual field and Multifocal electroretinography assessment. Visual field defect after vitrectomy a well known post operative complication usually in eyes that underwent fluid air exchange, the cause of visual field defect remain unclear.

Optical Coherence Tomography (OCT), imaging is done to evaluate inner retinal layers after ILM peeling,High myopic eyes might develop more severe, "scattered" inner retinal defects after ILM peeling.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date April 8, 2021
Est. primary completion date February 9, 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 80 Years
Eligibility Inclusion Criteria:

1. 1-Idiopathic ERM,

2. Primary full thickness macular hole,

3. Lamellar macular hole, and

4. Vitromacular traction.

Exclusion Criteria:

- 1-Patients with a secondary ERM,

1. diabetic retinopathy,

2. venous occlusion,

3. retinal detachment,

4. uveitis, and

5. trauma. 2-Other ocular pathologies that could interfere with the functional results

1. dense cataract ,

2. glaucoma, and

3. previous retinal surgery.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Higashide T, Ohkubo S, Hangai M, Ito Y, Shimada N, Ohno-Matsui K, Terasaki H, Sugiyama K, Chew P, Li KK, Yoshimura N. Influence of Clinical Factors and Magnification Correction on Normal Thickness Profiles of Macular Retinal Layers Using Optical Coherence — View Citation

Noma H, Funatsu H, Sakata K, Harino S, Mimura T, Hori S. Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion. Acta Ophthalmol. 2009 Sep;87(6):638-42. doi: 10.1111/j.1755-3768.2008.01318.x. Epub 2008 Jul 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary BCVA ILM peeling 6 months